Understand the UK's tightly controlled medical cannabis laws in 2026, including patient eligibility, prescribing pathways, and the clear distinction betwe… The landscape of medical cannabis ...

Picking a JavaScript framework in 2026 is not the casual decision it was a decade ago. The framework you choose today will shape your application’s performance, security posture, hiring costs, and ...

OUSG operates as a Delaware limited partnership investing through BlackRock’s BUIDL fund into US Treasuries. USDY holders are secured creditors of a special purpose vehicle backed by US Treasuries and ...

Lockheed Martin and Northrop Grumman are two of the best-known and most significant defense stocks around. Over the last two years, each company has grown its trailing 12-month revenue by the ...

PCWorld highlights the Framework Laptop 13 Pro’s transformation into a premium device with solid aluminum construction, addressing previous models’ build quality issues while maintaining modular ...

Framework has been selling and shipping its modular, repairable, upgradable Laptop 13 for five years now, and in that time, it has released six distinct versions of its system board, each using fresh ...

For the fastest way to join Tom's Guide Club enter your email below. We'll send you a confirmation and sign you up to our newsletter to keep you updated on all the latest news.

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Erik Steiger discusses the operational pain ...

The data were also used to develop a normative model, a statistical framework for understanding atypical biological features by comparing an individual to a reference population, and a data-clustering ...

A new paper was published in Volume 13 of Oncoscience on February 6, 2026, titled "Gastrointestinal toxicity of targeted cancer therapies in the United States: Clinicopathologic patterns, FDA safety ...